Last10K.com

Sarepta Therapeutics, Inc. (SRPT) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Sarepta Therapeutics, Inc.

HISTORY TOOLS
CIK: 873303 Ticker: SRPT

View differences made from one to another to evaluate Sarepta Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sarepta Therapeutics, Inc..

Continue

Assess how Sarepta Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sarepta Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: SRPT
CIK: 873303
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-006311
Submitted to the SEC: Tue Mar 05 2019 5:07:26 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Tuesday, March 5, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/srpt/0001564590-19-006311.htm